Waqaas Al-Siddiq - Mar 12, 2023 Form 4 Insider Report for BIOTRICITY INC. (BTCY)

Role
President, CEO and Chairman, Director
Signature
/s/ Waqaas Al-Siddiq
Stock symbol
BTCY
Transactions as of
Mar 12, 2023
Transactions value $
$0
Form type
4
Date filed
3/14/2023, 04:26 PM

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BTCY Option (right to purchase) Award $0 +350K +10.94% $0.00 3.55M Mar 12, 2023 Common Stock 350K $1.25 Direct F1
transaction BTCY Option (right to purchase) Award $0 +350K +9.86% $0.00 3.9M Mar 12, 2023 Common Stock 350K $1.75 Direct F1
transaction BTCY Option (right to purchase) Award $0 +1M +25.64% $0.00 4.9M Mar 12, 2023 Common Stock 1M $0.81 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Granted pursuant to the 2016 Equity Incentive Plan, with 175,000 of the Option vested January 27, 2023, and the remaining unvested Option of 175,000 will vest on January 27, 2024.
F2 Granted pursuant to the 2016 Equity Incentive Plan, with 250,000 of the Option vested January 27, 2023, and the remaining unvested Option of 20,833 will become vested and exercisable every month thereafter starting on February 27, 2023, until the Option is 100% vested.